OneMedNet Corp Cash Flow Statement
ONMD|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$7M
FY2025
Free Cash Flow
-$7M
FY2025
Capital Expenditures
$51,000
Cash used for long-term assets
Dividends Paid
N/A
FY2025
OneMedNet Corp used $7M in operating cash flow and negative free cash flow of $7M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$10.1M | -$33.8M | -$6.2M |
| Depreciation & Amortization | $57.0K | $28.0K | $24.8K |
| Operating Cash Flow | -$7.0M | -$4.8M | $87.2M |
| Capital Expenditures | $51.0K | $44.0K | $58.1K |
| Free Cash Flow | -$7.0M | -$4.8M | $87.2M |
| FCF Margin | -1089.1% | -473.6% | 7563.0% |